Chemoproteomics Reveals That Quaternary Protoberberine Alkaloids Inhibit Telomerase Activity Oncologically by Binding to PES1

Chem Biodivers. 2023 May;20(5):e202300230. doi: 10.1002/cbdv.202300230. Epub 2023 Apr 4.

Abstract

Natural QPAs have anti-cancer property. The prodrugs of QPAs synthesized in our work with significantly improved solubility showed significantly stronger activity in animal experiments. Nevertheless, the mechanism of action of QPAs for treating cancers remains poorly understood. Here, a chemoproteomic study reveals that QPAs non-covalently and multivalently bind to PES1 in CRC cells, which impinges on the direct interaction between hTERT and hTR in the assembly of the telomerase complex, downregulates telomerase activity, and so promotes the aging process of CRC cells. This study is beneficial for us to conduct extensively the pharmaceutical chemistry research of QPAs.

Keywords: CESTA; Pescadillo ribosomal biogenesis factor 1; activity-based protein profiling; colorectal cancer; quaternary protoberberine alkaloids.

MeSH terms

  • Animals
  • Berberine Alkaloids*
  • RNA / chemistry
  • Telomerase* / metabolism

Substances

  • Telomerase
  • protoberberine
  • Berberine Alkaloids
  • RNA

Grants and funding